Sandu Pharmaceuticals Stock Screener | Share Price & Fundamental Analysis
SANDUPHQ
Pharmaceuticals
Screen Sandu Pharmaceuticals share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹37.70
▼
-0.96 (-2.48%)
Market Cap
₹37.70 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
1.13
EPS (TTM)
₹1.60
Dividend Yield
2.05%
Debt to Equity
-
52W High
₹56.91
52W Low
₹37.43
Operating Margin
3.00%
Profit Margin
-
Revenue (TTM)
₹14.00
EBITDA
₹1.00
Net Income
-
Total Assets
₹56.00
Total Equity
₹42.00
Sandu Pharmaceuticals Share Price History - Stock Screener Chart
Screen SANDUPHQ historical share price movements with interactive charts. Analyze price trends and patterns.
Sandu Pharmaceuticals Company Profile - Fundamental Screener
Screen Sandu Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SANDUPHQ shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE751D01014
Sandu Pharmaceuticals Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen SANDUPHQ balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Assets | |||
| Total Assets | 56 | 52 | 54 |
| Current Assets | 26 | 22 | 26 |
| Fixed Assets | 18 | 18 | 17 |
| Liabilities | |||
| Total Liabilities | 56 | 52 | 54 |
| Current Liabilities | 2 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 |
| Shareholders' Equity | |||
| Total Equity | 42 | 41 | 39 |
| Share Capital | 10 | 10 | 10 |
| Reserves & Surplus | 32 | 31 | 30 |
Screen SANDUPHQ income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec | 2021-Jun | 2021-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14 | 16 | 17 | 18 | 18 | 15 | 18 | 17 | 18 | 12 | 16 | 17 | 17 | 17 | 18 |
| Expenses | 14 | 15 | 17 | 17 | 17 | 15 | 17 | 16 | 17 | 11 | 16 | 16 | 16 | 17 | 17 |
| EBITDA | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 |
| Operating Profit % | 3.00% | 4.00% | 2.00% | 5.00% | 5.00% | 3.00% | 2.00% | 5.00% | 3.00% | 5.00% | 2.00% | 5.00% | 5.00% | 4.00% | 5.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
| EPS | 0.34 | 0.62 | 0.17 | 1.95 | 0.57 | 0.26 | 0.11 | 0.57 | 0.21 | 0.34 | 0.19 | 0.64 | 0.51 | 0.53 | 0.57 |
Sandu Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen SANDUPHQ cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March |
|---|---|---|---|
| Operating Activities | 1 | 1 | 0 |
| Investing Activities | 0 | -1 | 1 |
| Financing Activities | -1 | -1 | 1 |
| Net Cash Flow | 0 | -1 | 1 |
Screen SANDUPHQ shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 42.90% | 42.90% | 42.90% | 42.90% | 42.90% | 42.90% | 42.90% | 52.41% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 36.77% | 36.57% | 35.90% | 44.16% | 44.25% | 34.97% | 35.34% | 35.72% |
| Other Holding | 20.32% | 20.53% | 21.20% | 12.93% | 12.84% | 22.12% | 21.75% | 11.86% |
| Shareholder Count | 10,284 | 10,226 | 10,287 | 10,001 | 10,012 | 10,246 | 10,333 | 10,141 |
Sandu Pharmaceuticals Dividend Screener - Share Yield Analysis
Screen SANDUPHQ dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹0.80 | 2.05% |
| 2024-March | ₹0.80 | 1.63% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.75 | 1.43% |
| 2021-March | ₹0.50 | 0.71% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
| 2016-March | ₹0.00 | 0.00% |
Sandu Pharmaceuticals Index Membership - Market Screener Classification
Screen SANDUPHQ by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Sandu Pharmaceuticals Market Events Screener - Corporate Actions
Screen SANDUPHQ market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 0.80 /share | -12.97% | ||
| Dividend | ₹ 0.75 /share | 5.08% | ||
| Dividend | ₹ 0.75 /share | 41.02% | ||
| Dividend | ₹ 0.80 /share | 4.55% | ||
| Annual General Meeting | NA | 3.42% | ||
| Dividend | ₹ 0.50 /share | 0.87% | ||
| Annual General Meeting | NA | -3.84% | ||
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -2.51% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 0.76% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 4.41% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -3.54% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 2.33% |
Sandu Pharmaceuticals Competitors Screener - Peer Comparison
Screen SANDUPHQ competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 427,394 | 40.80 | 54,729 | 9.71% | 10,980 | 52.10 |
| Divis Laboratories | 168,188 | 67.69 | 9,712 | 18.67% | 2,191 | 43.07 |
| Torrent Pharmaceuticals | 127,428 | 59.43 | 11,539 | 6.99% | 1,911 | 54.16 |
| Cipla | 121,131 | 22.30 | 28,410 | 7.12% | 5,291 | 43.47 |
| Dr Reddys Laboratories | 106,572 | 18.61 | 33,741 | 16.73% | 5,725 | 58.35 |
| Lupin | 95,489 | 21.96 | 22,910 | 13.74% | 3,306 | 58.83 |
| Zydus Life Science | 92,005 | 18.29 | 23,511 | 18.55% | 4,615 | 35.18 |
| Mankind Pharma | 86,927 | 49.02 | 12,744 | 20.90% | 2,007 | 25.12 |
| Aurobindo Pharma | 68,424 | 20.00 | 32,346 | 9.43% | 3,484 | 47.36 |
| Alkem Laboratories | 67,716 | 28.08 | 13,458 | 3.70% | 2,216 | 52.38 |
Sandu Pharmaceuticals Company Announcements - News Screener
Screen SANDUPHQ latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-19 | : Intimation Regarding Receipt Of Approval Of Shareholders For Reclassification Of M/S Akshath Finvest And Properties Private Limited Persons Forming Part Of The Promoter/Promoter Group Category To The Public Category. | View |
| 2025-11-19 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-11-19 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-12 | Statement Of Deviation And Variation For The Quarter Ended 30.09.2025 | View |
| 2025-11-12 | Unaudited Financial Results For The Q And Half Year Ended 30.09.2025 | View |
| 2025-11-12 | Board Meeting Outcome for Outcome Of The Board Meeting Dated 12.11.2025 | View |
| 2025-11-05 | Board Meeting Intimation for Approval Of Standalone Unaudited Financial Results For Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-10-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-17 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2025-10-14 | Approval Of The Draft Postal Ballot Notice And Explanatory Statement | View |
| 2025-10-14 | Board Meeting Outcome for Outcome Of The Board Meeting Dated 14Th October 2025 | View |
| 2025-10-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-04 | Board Meeting Intimation for 1. To Approve Notice Of Postal Ballot For Reclassification Of M/S Akshath Finvest And Properties Private Limited From Promoter/ Promoter Group Category To Public Category | View |
| 2025-10-01 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-10-01 | Announcement Under Regulation 30-Appointment Of Secretarial Auditor | View |
| 2025-10-01 | Announcement Under Regulation 30-Update-Agenda Items Approved By Shareholders At The 40Th Annual General Meeting | View |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |